nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—IL1B—synovial fluid—ankylosing spondylitis	0.0746	0.153	CbGeAlD
Gallium nitrate—IL1B—knee—ankylosing spondylitis	0.0673	0.138	CbGeAlD
Gallium nitrate—BGLAP—skeletal joint—ankylosing spondylitis	0.0565	0.115	CbGeAlD
Gallium nitrate—IL1B—skeletal joint—ankylosing spondylitis	0.0483	0.0987	CbGeAlD
Gallium nitrate—BGLAP—vertebral column—ankylosing spondylitis	0.0449	0.0917	CbGeAlD
Gallium nitrate—IL1B—vertebral column—ankylosing spondylitis	0.0384	0.0784	CbGeAlD
Gallium nitrate—BGLAP—cartilage tissue—ankylosing spondylitis	0.038	0.0776	CbGeAlD
Gallium nitrate—IL1B—synovial membrane of synovial joint—ankylosing spondylitis	0.0367	0.075	CbGeAlD
Gallium nitrate—TF—vertebral column—ankylosing spondylitis	0.0342	0.07	CbGeAlD
Gallium nitrate—IL1B—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0326	0.0744	CbGpPWpGaD
Gallium nitrate—IL1B—cartilage tissue—ankylosing spondylitis	0.0325	0.0664	CbGeAlD
Gallium nitrate—IL1B—Interleukin-1 processing—IL1A—ankylosing spondylitis	0.0222	0.0506	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.0215	0.0491	CbGpPWpGaD
Gallium nitrate—IL1B—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.0184	0.042	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.0163	0.0371	CbGpPWpGaD
Gallium nitrate—IL1B—Interleukin-1 signaling—IL1R2—ankylosing spondylitis	0.0162	0.0369	CbGpPWpGaD
Gallium nitrate—IL1B—NOD pathway—CARD9—ankylosing spondylitis	0.0137	0.0313	CbGpPWpGaD
Gallium nitrate—IL1B—IL27-mediated signaling events—IL17A—ankylosing spondylitis	0.0114	0.0259	CbGpPWpGaD
Gallium nitrate—IL1B—IL27-mediated signaling events—IL12B—ankylosing spondylitis	0.0106	0.0241	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL12B—ankylosing spondylitis	0.0103	0.0234	CbGpPWpGaD
Gallium nitrate—IL1B—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.00871	0.0199	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.00857	0.0195	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.00797	0.0182	CbGpPWpGaD
Gallium nitrate—IL1B—Interleukin-1 signaling—IL1RN—ankylosing spondylitis	0.00765	0.0174	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—tendon—ankylosing spondylitis	0.00759	0.0155	CbGeAlD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL1A—ankylosing spondylitis	0.00754	0.0172	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL10—ankylosing spondylitis	0.00749	0.0171	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL1R2—ankylosing spondylitis	0.0073	0.0167	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00714	0.0163	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00669	0.0153	CbGpPWpGaD
Gallium nitrate—IL1B—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.00627	0.0143	CbGpPWpGaD
Gallium nitrate—IL1B—tendon—ankylosing spondylitis	0.00555	0.0113	CbGeAlD
Gallium nitrate—IL1B—Type II interferon signaling (IFNG)—HLA-B—ankylosing spondylitis	0.00554	0.0126	CbGpPWpGaD
Gallium nitrate—IL1B—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.0055	0.0125	CbGpPWpGaD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—IL1A—ankylosing spondylitis	0.0055	0.0125	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—IL12B—ankylosing spondylitis	0.00541	0.0123	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.00513	0.0117	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-C—ankylosing spondylitis	0.00511	0.0116	CbGpPWpGaD
Gallium nitrate—RRM2—tendon—ankylosing spondylitis	0.00489	0.00999	CbGeAlD
Gallium nitrate—TF—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00481	0.011	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL17A—ankylosing spondylitis	0.00467	0.0106	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.00462	0.0105	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL12B—ankylosing spondylitis	0.00434	0.0099	CbGpPWpGaD
Gallium nitrate—IL1B—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.00427	0.00973	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.00421	0.00959	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00391	0.00892	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00379	0.00864	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00373	0.0085	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.00354	0.00807	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—HLA-A—ankylosing spondylitis	0.00349	0.00795	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.00345	0.00788	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.00341	0.00777	CbGpPWpGaD
Gallium nitrate—IL1B—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00336	0.00766	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00332	0.00757	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL1A—ankylosing spondylitis	0.00319	0.00728	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL10—ankylosing spondylitis	0.00318	0.00724	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—CD40LG—ankylosing spondylitis	0.00318	0.00724	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—CRP—ankylosing spondylitis	0.00308	0.00703	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ANTXR2—ankylosing spondylitis	0.00303	0.0069	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-B—ankylosing spondylitis	0.00302	0.00689	CbGpPWpGaD
Gallium nitrate—IL1B—IL27-mediated signaling events—TNF—ankylosing spondylitis	0.00294	0.0067	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.00288	0.00656	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TNF—ankylosing spondylitis	0.00285	0.0065	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—HLA-A—ankylosing spondylitis	0.0028	0.00638	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.00276	0.0063	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00257	0.00587	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.00254	0.0058	CbGpPWpGaD
Gallium nitrate—IL1B—Monoamine Transport—TNF—ankylosing spondylitis	0.00249	0.00568	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.00249	0.00567	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.00245	0.00558	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00239	0.00545	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00238	0.00542	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.00232	0.00528	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.00222	0.00505	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.00209	0.00476	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.00186	0.00425	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.00186	0.00423	CbGpPWpGaD
Gallium nitrate—Blindness—Triamcinolone—ankylosing spondylitis	0.00186	0.0378	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.00186	0.00423	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00185	0.00422	CbGpPWpGaD
Gallium nitrate—Blindness—Methylprednisolone—ankylosing spondylitis	0.00185	0.0378	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00184	0.0042	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KIR3DL1—ankylosing spondylitis	0.00184	0.00419	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Prednisolone—ankylosing spondylitis	0.00182	0.037	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—B3GNT2—ankylosing spondylitis	0.00178	0.00407	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.00175	0.00398	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Dexamethasone—ankylosing spondylitis	0.00174	0.0753	CbGdCrCtD
Gallium nitrate—IL1B—Methylprednisolone—Betamethasone—ankylosing spondylitis	0.00174	0.0753	CbGdCrCtD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.00171	0.00391	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Triamcinolone—ankylosing spondylitis	0.0017	0.0736	CbGdCrCtD
Gallium nitrate—Blindness—Betamethasone—ankylosing spondylitis	0.00168	0.0343	CcSEcCtD
Gallium nitrate—Blindness—Dexamethasone—ankylosing spondylitis	0.00168	0.0343	CcSEcCtD
Gallium nitrate—Optic neuritis—Triamcinolone—ankylosing spondylitis	0.00167	0.0341	CcSEcCtD
Gallium nitrate—Optic neuritis—Methylprednisolone—ankylosing spondylitis	0.00167	0.034	CcSEcCtD
Gallium nitrate—Rales—Methotrexate—ankylosing spondylitis	0.00165	0.0337	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00163	0.00371	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.00161	0.00368	CbGpPWpGaD
Gallium nitrate—IL1B—Methylprednisolone—Prednisone—ankylosing spondylitis	0.00161	0.0699	CbGdCrCtD
Gallium nitrate—IL1B—Methylprednisolone—Prednisolone—ankylosing spondylitis	0.00157	0.0682	CbGdCrCtD
Gallium nitrate—Optic neuritis—Dexamethasone—ankylosing spondylitis	0.00152	0.0309	CcSEcCtD
Gallium nitrate—Optic neuritis—Betamethasone—ankylosing spondylitis	0.00152	0.0309	CcSEcCtD
Gallium nitrate—Lung infiltration—Methotrexate—ankylosing spondylitis	0.00145	0.0295	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TNF—ankylosing spondylitis	0.0014	0.00318	CbGpPWpGaD
Gallium nitrate—Optic neuritis—Prednisone—ankylosing spondylitis	0.00132	0.0269	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—TNF—ankylosing spondylitis	0.00121	0.00276	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—TNF—ankylosing spondylitis	0.00121	0.00276	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.00116	0.00265	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL1R2—ankylosing spondylitis	0.00111	0.00254	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.00111	0.00253	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.0011	0.0025	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Methylprednisolone—ankylosing spondylitis	0.00109	0.0474	CbGdCrCtD
Gallium nitrate—IL1B—Fluorometholone—Dexamethasone—ankylosing spondylitis	0.00108	0.0467	CbGdCrCtD
Gallium nitrate—IL1B—Fluorometholone—Betamethasone—ankylosing spondylitis	0.00108	0.0467	CbGdCrCtD
Gallium nitrate—Encephalopathy—Methotrexate—ankylosing spondylitis	0.00106	0.0216	CcSEcCtD
Gallium nitrate—IL1B—Immune System—ERAP1—ankylosing spondylitis	0.00106	0.00241	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Triamcinolone—ankylosing spondylitis	0.00105	0.0456	CbGdCrCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.00102	0.00232	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Prednisone—ankylosing spondylitis	0.000998	0.0433	CbGdCrCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000985	0.00225	CbGpPWpGaD
Gallium nitrate—IL1B—Fluorometholone—Prednisolone—ankylosing spondylitis	0.000974	0.0423	CbGdCrCtD
Gallium nitrate—IL1B—Immune System—CARD9—ankylosing spondylitis	0.000965	0.0022	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000904	0.00206	CbGpPWpGaD
Gallium nitrate—Pleural effusion—Methotrexate—ankylosing spondylitis	0.000886	0.0181	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—TNF—ankylosing spondylitis	0.000877	0.002	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000857	0.00195	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000769	0.00175	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Methylprednisolone—ankylosing spondylitis	0.00073	0.0317	CbGdCrCtD
Gallium nitrate—ATP6V1B2—Disease—HLA-A—ankylosing spondylitis	0.000722	0.00165	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Dexamethasone—ankylosing spondylitis	0.000718	0.0312	CbGdCrCtD
Gallium nitrate—IL1B—Budesonide—Betamethasone—ankylosing spondylitis	0.000718	0.0312	CbGdCrCtD
Gallium nitrate—IL1B—Budesonide—Triamcinolone—ankylosing spondylitis	0.000702	0.0305	CbGdCrCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000701	0.0016	CbGpPWpGaD
Gallium nitrate—Lethargy—Betamethasone—ankylosing spondylitis	0.000691	0.0141	CcSEcCtD
Gallium nitrate—Lethargy—Dexamethasone—ankylosing spondylitis	0.000691	0.0141	CcSEcCtD
Gallium nitrate—IL1B—Budesonide—Prednisone—ankylosing spondylitis	0.000666	0.0289	CbGdCrCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000661	0.00151	CbGpPWpGaD
Gallium nitrate—IL1B—Budesonide—Prednisolone—ankylosing spondylitis	0.00065	0.0282	CbGdCrCtD
Gallium nitrate—RRM2—Metabolism—B3GNT2—ankylosing spondylitis	0.000646	0.00147	CbGpPWpGaD
Gallium nitrate—Coma—Methotrexate—ankylosing spondylitis	0.00062	0.0126	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MMP3—ankylosing spondylitis	0.00061	0.00139	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HLA-C—ankylosing spondylitis	0.000606	0.00138	CbGpPWpGaD
Gallium nitrate—Lethargy—Prednisone—ankylosing spondylitis	0.000602	0.0123	CcSEcCtD
Gallium nitrate—Renal failure acute—Methotrexate—ankylosing spondylitis	0.000534	0.0109	CcSEcCtD
Gallium nitrate—IL1B—Immune System—IL1RN—ankylosing spondylitis	0.000527	0.0012	CbGpPWpGaD
Gallium nitrate—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000512	0.0104	CcSEcCtD
Gallium nitrate—Lethargy—Methotrexate—ankylosing spondylitis	0.000503	0.0103	CcSEcCtD
Gallium nitrate—Erythema—Prednisolone—ankylosing spondylitis	0.000489	0.00996	CcSEcCtD
Gallium nitrate—Hallucination—Betamethasone—ankylosing spondylitis	0.000466	0.0095	CcSEcCtD
Gallium nitrate—Hallucination—Dexamethasone—ankylosing spondylitis	0.000466	0.0095	CcSEcCtD
Gallium nitrate—IL1B—Immune System—CD79A—ankylosing spondylitis	0.000462	0.00105	CbGpPWpGaD
Gallium nitrate—Erythema—Triamcinolone—ankylosing spondylitis	0.000449	0.00916	CcSEcCtD
Gallium nitrate—Erythema—Methylprednisolone—ankylosing spondylitis	0.000448	0.00914	CcSEcCtD
Gallium nitrate—IL1B—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000446	0.0194	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000446	0.0194	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000439	0.0191	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000439	0.0191	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000429	0.0186	CbGdCrCtD
Gallium nitrate—IL1B—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000429	0.0186	CbGdCrCtD
Gallium nitrate—Erythema—Betamethasone—ankylosing spondylitis	0.000408	0.00831	CcSEcCtD
Gallium nitrate—Erythema—Dexamethasone—ankylosing spondylitis	0.000408	0.00831	CcSEcCtD
Gallium nitrate—IL1B—Betamethasone—Prednisone—ankylosing spondylitis	0.000407	0.0177	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Prednisone—ankylosing spondylitis	0.000407	0.0177	CbGdCrCtD
Gallium nitrate—Hallucination—Prednisone—ankylosing spondylitis	0.000406	0.00827	CcSEcCtD
Gallium nitrate—IL1B—Betamethasone—Prednisolone—ankylosing spondylitis	0.000398	0.0173	CbGdCrCtD
Gallium nitrate—IL1B—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000398	0.0173	CbGdCrCtD
Gallium nitrate—Tachycardia—Prednisolone—ankylosing spondylitis	0.000389	0.00793	CcSEcCtD
Gallium nitrate—IL1B—Immune System—IL1A—ankylosing spondylitis	0.000379	0.000864	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CD40LG—ankylosing spondylitis	0.000377	0.000859	CbGpPWpGaD
Gallium nitrate—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000369	0.00752	CcSEcCtD
Gallium nitrate—IL1B—Immune System—HLA-B—ankylosing spondylitis	0.000358	0.000817	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000358	0.0073	CcSEcCtD
Gallium nitrate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000358	0.0073	CcSEcCtD
Gallium nitrate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000357	0.00728	CcSEcCtD
Gallium nitrate—Erythema—Prednisone—ankylosing spondylitis	0.000355	0.00724	CcSEcCtD
Gallium nitrate—IL1B—Immune System—HLA-A—ankylosing spondylitis	0.000332	0.000757	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000329	0.00671	CcSEcCtD
Gallium nitrate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000329	0.0067	CcSEcCtD
Gallium nitrate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000329	0.0067	CcSEcCtD
Gallium nitrate—Anaemia—Prednisone—ankylosing spondylitis	0.000328	0.00669	CcSEcCtD
Gallium nitrate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000327	0.00666	CcSEcCtD
Gallium nitrate—Tachycardia—Betamethasone—ankylosing spondylitis	0.000325	0.00662	CcSEcCtD
Gallium nitrate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000325	0.00662	CcSEcCtD
Gallium nitrate—Tinnitus—Methotrexate—ankylosing spondylitis	0.000318	0.00648	CcSEcCtD
Gallium nitrate—IL1B—Immune System—CRP—ankylosing spondylitis	0.000317	0.000722	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TLR4—ankylosing spondylitis	0.000304	0.000693	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000302	0.00616	CcSEcCtD
Gallium nitrate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000301	0.00615	CcSEcCtD
Gallium nitrate—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000299	0.00609	CcSEcCtD
Gallium nitrate—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000299	0.00609	CcSEcCtD
Gallium nitrate—Erythema—Methotrexate—ankylosing spondylitis	0.000297	0.00605	CcSEcCtD
Gallium nitrate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000294	0.00599	CcSEcCtD
Gallium nitrate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00029	0.00591	CcSEcCtD
Gallium nitrate—Tachycardia—Prednisone—ankylosing spondylitis	0.000283	0.00577	CcSEcCtD
Gallium nitrate—Anaemia—Methotrexate—ankylosing spondylitis	0.000274	0.00559	CcSEcCtD
Gallium nitrate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000274	0.00559	CcSEcCtD
Gallium nitrate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000274	0.00559	CcSEcCtD
Gallium nitrate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00027	0.00551	CcSEcCtD
Gallium nitrate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00027	0.0055	CcSEcCtD
Gallium nitrate—Leukopenia—Methotrexate—ankylosing spondylitis	0.000266	0.00541	CcSEcCtD
Gallium nitrate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000263	0.00536	CcSEcCtD
Gallium nitrate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000263	0.00536	CcSEcCtD
Gallium nitrate—Paraesthesia—Prednisone—ankylosing spondylitis	0.00026	0.0053	CcSEcCtD
Gallium nitrate—Pruritus—Triamcinolone—ankylosing spondylitis	0.000259	0.00529	CcSEcCtD
Gallium nitrate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000259	0.00528	CcSEcCtD
Gallium nitrate—Rash—Prednisolone—ankylosing spondylitis	0.000251	0.00513	CcSEcCtD
Gallium nitrate—Dermatitis—Prednisolone—ankylosing spondylitis	0.000251	0.00512	CcSEcCtD
Gallium nitrate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00025	0.0051	CcSEcCtD
Gallium nitrate—Constipation—Prednisone—ankylosing spondylitis	0.000248	0.00505	CcSEcCtD
Gallium nitrate—Confusional state—Methotrexate—ankylosing spondylitis	0.000244	0.00498	CcSEcCtD
Gallium nitrate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000239	0.00487	CcSEcCtD
Gallium nitrate—Nausea—Prednisolone—ankylosing spondylitis	0.000237	0.00483	CcSEcCtD
Gallium nitrate—Pruritus—Dexamethasone—ankylosing spondylitis	0.000235	0.0048	CcSEcCtD
Gallium nitrate—Pruritus—Betamethasone—ankylosing spondylitis	0.000235	0.0048	CcSEcCtD
Gallium nitrate—Vomiting—Triamcinolone—ankylosing spondylitis	0.000233	0.00475	CcSEcCtD
Gallium nitrate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000233	0.00474	CcSEcCtD
Gallium nitrate—Rash—Triamcinolone—ankylosing spondylitis	0.000231	0.00471	CcSEcCtD
Gallium nitrate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000231	0.00471	CcSEcCtD
Gallium nitrate—Rash—Methylprednisolone—ankylosing spondylitis	0.000231	0.0047	CcSEcCtD
Gallium nitrate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00023	0.0047	CcSEcCtD
Gallium nitrate—Body temperature increased—Prednisone—ankylosing spondylitis	0.000229	0.00467	CcSEcCtD
Gallium nitrate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000228	0.00464	CcSEcCtD
Gallium nitrate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000228	0.00464	CcSEcCtD
Gallium nitrate—Nausea—Triamcinolone—ankylosing spondylitis	0.000218	0.00444	CcSEcCtD
Gallium nitrate—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000217	0.00443	CcSEcCtD
Gallium nitrate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000217	0.00443	CcSEcCtD
Gallium nitrate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000216	0.0044	CcSEcCtD
Gallium nitrate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000213	0.00435	CcSEcCtD
Gallium nitrate—Vomiting—Betamethasone—ankylosing spondylitis	0.000212	0.00431	CcSEcCtD
Gallium nitrate—Vomiting—Dexamethasone—ankylosing spondylitis	0.000212	0.00431	CcSEcCtD
Gallium nitrate—Rash—Dexamethasone—ankylosing spondylitis	0.00021	0.00428	CcSEcCtD
Gallium nitrate—Rash—Betamethasone—ankylosing spondylitis	0.00021	0.00428	CcSEcCtD
Gallium nitrate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00021	0.00427	CcSEcCtD
Gallium nitrate—Dermatitis—Betamethasone—ankylosing spondylitis	0.00021	0.00427	CcSEcCtD
Gallium nitrate—Pruritus—Prednisone—ankylosing spondylitis	0.000205	0.00418	CcSEcCtD
Gallium nitrate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0002	0.00407	CcSEcCtD
Gallium nitrate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000198	0.00404	CcSEcCtD
Gallium nitrate—Nausea—Betamethasone—ankylosing spondylitis	0.000198	0.00403	CcSEcCtD
Gallium nitrate—Nausea—Dexamethasone—ankylosing spondylitis	0.000198	0.00403	CcSEcCtD
Gallium nitrate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000191	0.0039	CcSEcCtD
Gallium nitrate—Vomiting—Prednisone—ankylosing spondylitis	0.000184	0.00376	CcSEcCtD
Gallium nitrate—Rash—Prednisone—ankylosing spondylitis	0.000183	0.00372	CcSEcCtD
Gallium nitrate—Dermatitis—Prednisone—ankylosing spondylitis	0.000183	0.00372	CcSEcCtD
Gallium nitrate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000178	0.00364	CcSEcCtD
Gallium nitrate—Nausea—Prednisone—ankylosing spondylitis	0.000172	0.00351	CcSEcCtD
Gallium nitrate—Pruritus—Methotrexate—ankylosing spondylitis	0.000171	0.00349	CcSEcCtD
Gallium nitrate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000166	0.00338	CcSEcCtD
Gallium nitrate—Vomiting—Methotrexate—ankylosing spondylitis	0.000154	0.00314	CcSEcCtD
Gallium nitrate—Rash—Methotrexate—ankylosing spondylitis	0.000153	0.00311	CcSEcCtD
Gallium nitrate—Dermatitis—Methotrexate—ankylosing spondylitis	0.000153	0.00311	CcSEcCtD
Gallium nitrate—Nausea—Methotrexate—ankylosing spondylitis	0.000144	0.00293	CcSEcCtD
